Opportunities and Challenges of Bacterial Extracellular Vesicles in Regenerative Medicine

    January 2025 in “ Journal of Nanobiotechnology
    Jiming Guo, Zhijie Huang, Qinjing Wang, Min Wang, Yue Ming, Weixing Chen, Yisheng Huang, Zhengming Tang, Mingshu Huang, Hongyu Liu, Bo Jia
    Studysummary This review discusses the potential of bacterial extracellular vesicles in regenerative medicine, highlighting their advantages in addressing current EV challenges, and provides strategies for optimizing their preparation; it reports no new clinical results.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    Bacterial extracellular vesicles (BEVs) show significant promise in regenerative medicine due to their stability, high production yield, and drug delivery capabilities. They offer advantages over synthetic nanomaterials and stem cell therapies, such as enhanced targeting and the ability to cross barriers like the blood-brain barrier. BEVs can promote tissue regeneration, bone healing, and combat antibiotic resistance. However, challenges like potential immune responses, toxicity, and production standardization need addressing. Engineering strategies, including genetic modifications, are being explored to improve their safety and functionality, making BEVs viable candidates for innovative therapies in regenerative medicine.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results